Innavac
Manufacturing · Australia · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Melbourne, Victoria, AustraliaWebsite
www.innavac.comRevenue
$5.1 MillionIndustry
About Innavac
Is Innavac your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Innavac had a recent Job posting/layoffs
Earning: See what the market has to say on Innavac recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Innavac launches new products
Congratulate Masked Content for being promoted to Masked Content at Innavac
Funding: Get notified immidiatlly once Innavac has new funding data
Innavac, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Innavac has recently received funding, and reach out quickly before it becomes old news!
Check out if Innavac is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Innavac as Masked Content
Find 2 more new buyers
Compare Similar Companies to Innavac
Compare insights from companies similar to Innavac, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Innavac
Company Profile Activity
Activity Insights
Innavac is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Innavac is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Innavac.
Innavac Tech Stack
A closer look at the technologies used by Innavac
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Innavac
ENA Respiratory is a clinical-stage pharmaceutical company focused on developing antiviral host defense enhancers to prevent severe complications from respiratory viral infections in vulnerable populations. Their lead product, INNA-051, is a first-in-class TLR2/6 agonist designed for self-administration via a nasal spray with a weekly dosing regime... Read More